Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125829282 | 12582928 | 2 | F | 20160627 | 20160722 | 20160722 | 20160729 | EXP | GB-PFIZER INC-2016345462 | PFIZER | 0.00 | M | Y | 0.00000 | 20160729 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125829282 | 12582928 | 1 | PS | DEFEROXAMINE MESILATE | DEFEROXAMINE MESYLATE | 1 | Subcutaneous | 2G IN 40ML (0.9% BP) SODIUM CHLORIDE 5 TIMES A WEEK | 76019 | POWDER FOR INJECTION | /wk | ||||||||
| 125829282 | 12582928 | 2 | SS | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Subcutaneous | 2G DESFERRIOXAMINE IN 40 ML (0.9% BP) SODIUM CHLORIDE 5 TIMES PER WEEK | 16366 | SOLUTION FOR INJECTION | /wk | ||||||||
| 125829282 | 12582928 | 3 | SS | WATER FOR INJECTION | WATER | 1 | UNK, WEEKLY | 17513 | SOLVENT FOR PARENTERAL USE | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125829282 | 12582928 | 2 | Medication dilution |
| 125829282 | 12582928 | 3 | Medication dilution |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125829282 | 12582928 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125829282 | 12582928 | Pyrexia | |
| 125829282 | 12582928 | Viral infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |